Eisai US’ Post

Early detection is key in managing cognitive decline. Michael Irizarry, MD, MPH, from Eisai US highlights why the progressive destructive nature of protofibrils makes them important therapeutic targets in Alzheimer's disease. Watch the full video: https://ow.ly/bLuu50StYq8 #AlzheimersDisease #EndAlz #Neurology

Demystifying Parkinson's Disease: Understanding the Pathophysiology! Delve into the intricate world of Parkinson's Disease and uncover the underlying mechanisms of neuronal death, protein aggregation, autophagy disruption, and more. Expand your knowledge of this complex neurological condition. 🔗 Read more: https://lnkd.in/gAUCWbxt #ParkinsonsDisease #Neurology #MedicalResearch #Science #BrainHealth

📹 Tune in as Dr. Julie Schwartzbard, board-certified neurologist and VIN's Chief Medical Officer, breaks down complex memory disorders into easy-to-understand concepts and advocates for the importance of clinical trials. Learn from one of the medical field's top experts. Click on the link below to view and gain valuable insights! #MemoryDisorders #Neurology #ExpertTalks #VINTrials https://lnkd.in/e6My3vgN 

This is why CSF is needed to evaluate protofibrils.

We are gearing up for a busy week at the American Academy of Neurology Annual Meeting. Stop by Booth 1325 to meet our team and discuss our latest Alzheimer’s disease research. Find information on our therapeutic update and other sessions on the meeting program: https://ow.ly/Jiw250R7xRX #AANAM #Neurology #AlzheimersDisease

ECTRIMS 2024 Takeaways Inspired by the breakthroughs and collaboration at ECTRIMS 2024. Excited to bring back new insights to enhance MS care in our region. Looking forward to applying these innovations to support patients and HCPs. #ECTRIMS2024 #MSCare #Innovation #Neurology

This year's #ECTRIMS2024 has a packed agenda with keynote speeches from renowned MS experts, popular formats like Scientific Sessions and Hot Topics, and much more. We are also thrilled to introduce the NEW ECTRIMS Pre-Day, focusing on Paediatric MS, #NMOSD, #MOGAD, and Autoimmune Encephalitis. 📅 Mark your calendar for September and stay tuned as we unveil more details about our engaging and informative sessions. View the Programme 👉 https://bit.ly/4a3bvi7 #MS #MultipleSclerosis #Neurology

Advance your neurology research with the Simoa® NfL assay, now available through Advantage Plus. 🧠 This highly sensitive laboratory test, designed for accurate measurement of neurofilament light (NfL) levels, is compatible with various sample types, including blood and CSF. Request more information to learn about its benefits and applications in research: https://bit.ly/3uhxP7V #Neurology #Biomarkers #SimoaAdvantagePlus

We’re almost at the end of #ADPD24 in Lisbon and we want to thank you for the engaging conversations, the insightful information, and our harmonious collaboration. Let’s finish strong and get ready for ADPD2025, where more breakthroughs in the field of neurology will be discussed! #clinicalresearch #neurology #ADPD 

Did you know? Spatial biology isn't just for scientists. It has the potential to transform patient care by providing clinicians with more accurate diagnostic tools and enabling them to develop more personalized treatment plans. Want to learn how spatial biology is impacting patient care? Read this article 👇 https://lnkd.in/eV6vPx3d #SpatialBiology #Diagnostics #TargetedBioscience #CancerResearch #Neurology #health